Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the SOFA-2 Score for 30-Day Mortality in Intensive Care Units in Turkey and Determination of Sepsis-3 Prevalence - A Multicenter Hybrid Observational Study.

NCT07300306 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT07300306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07300306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the SOFA-2 Score for 30-Day Mortality in Intensive Care Units in Turkey and Determination of Sepsis-3 Prevalence - A Multicenter Hybrid Observational Study.
Lead sponsor
Marmara University
Phase
Observational
Overall status
Completed
Start date
May 4, 2026
Completion date
August 10, 2026
Enrollment
3,379 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, organ dysfunction, sepsis, septic shock